Sensus Healthcare Forms Strategic Agreement with SkinCure Oncology


Sensus Healthcare, Inc., which specializes in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), formed a strategic agreement focused on marketing the SRT-100 Vision with SkinCure Oncology, a leading turnkey provider of IGSRT solutions in the dermatology industry. SkinCure uses the same quality and safety features of leading cancer center models for the delivery of Sensus’ SRT-100 Visionto  dermatology practices.
“Sensus’ strategic relationship with SkinCure Oncology is representative of our customer-centric approach in supporting the dermatology community, not to mention a valuable resource to further expand our market position,” says Joe Sardano, chairman and chief executive officer of Sensus Healthcare. “We look forward to continue working in lock-step with the SkinCure team, a proven partner of Sensus, to lead the industry and provide the most effective IGSRT solution available to patients in need all over the country.”
The SRT-100 Vision is built with all of the same features and efficacy of the SRT-100 and delivers precise, calibrated doses of SRT, while also offering high-frequency ultrasound for imaging. The SRT-100 Vision allows for basal and squamous cell carcinomas, as well as keloid tissue, to be assessed more thoroughly and treatment to be more precisely targeted.
When the ultrasound is placed over the treatment area using the laser positioning system, doctors can assess the lesion to see how deep it is and fine-tune the exact amount of radiation that is needed. The device also allows physicians to better assess how the lesion is progressing with each treatment session, while recording each session for the patient’s records via the LesionCam.
"We entered into this agreement with Sensus based on our belief in its technology and market lead in IGSRT delivery systems,” adds Kerwin Brandt, CEO, Skincure Oncology. “Our unique delivery model provides the capital, human resources and expertise, thereby allowing dermatology practices to deliver daily cutting-edge IGSRT treatments to patients. Through the SkinCure solution, we provide the Sensus SRT-100 Vision unit and suite buildout, address state regulatory requirements and give access to radiation oncologists for consultation and full-time board-certified radiation therapists to deliver treatments. We provide a patient-focused solution that continues to deliver excellent clinical outcomes – all of the while minimizing headaches for clinicians.”

Facebook Comments


We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free